MLICM
ANAB icon

Metropolitan Life Insurance Company (MetLife)’s AnaptysBio ANAB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,211
Closed -$27.3K – 137
2024
Q1 		$27.3K Hold
1,211
– – ﹤0.01% 1704
2023
Q4 		$25.9K Hold
1,211
– – ﹤0.01% 1799
2023
Q3 		$21.8K Hold
1,211
– – ﹤0.01% 1855
2023
Q2 		$24.6K Hold
1,211
– – ﹤0.01% 1819
2023
Q1 		$26.4K Hold
1,211
– – ﹤0.01% 1741
2022
Q4 		$37.5K Hold
1,211
– – ﹤0.01% 1642
2022
Q3 		$30.9K Hold
1,211
– – ﹤0.01% 1787
2022
Q2 		$24.6K Hold
1,211
– – ﹤0.01% 1940
2022
Q1 		$30K Sell
1,211
-4,419
-78% -$134K ﹤0.01% 1884
2021
Q4 		$196K Hold
5,630
– – ﹤0.01% 2043
2021
Q3 		$153K Sell
5,630
-2,367
-30% -$60.1K ﹤0.01% 2278
2021
Q2 		$207K Buy
7,997
+546
+7% +$13.1K ﹤0.01% 2111
2021
Q1 		$161K Sell
7,451
-703
-9% -$17.7K ﹤0.01% 2166
2020
Q4 		$175K Hold
8,154
– – ﹤0.01% 2017
2020
Q3 		$120K Hold
8,154
– – ﹤0.01% 2110
2020
Q2 		$182K Hold
8,154
– – ﹤0.01% 1865
2020
Q1 		$115K Hold
8,154
– – ﹤0.01% 1948
2019
Q4 		$133K Hold
8,154
– – ﹤0.01% 2166
2019
Q3 		$285K Buy
8,154
+1,012
+14% +$48.1K ﹤0.01% 1632
2019
Q2 		$403K Buy
7,142
+197
+3% +$14.2K 0.01% 1441
2019
Q1 		$507K Hold
6,945
– – 0.01% 1288
2018
Q4 		$443K Buy
6,945
+1,154
+20% +$85.8K 0.01% 1269
2018
Q3 		$578K Hold
5,791
– – 0.01% 1256
2018
Q2 		$411K Hold
5,791
– – 0.01% 1450
2018
Q1 		$603K Buy
5,791
+134
+2% +$15.1K 0.01% 1156
2017
Q4 		$570K Sell
5,657
-3,003
-35% -$221K 0.01% 1201
2017
Q3 		$303K Buy
+8,660
New +$234K ﹤0.01% 2024

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ANAB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of AnaptysBio (ANAB) in Q2 2024, closing a stake of 1,211 shares — an estimated $27.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ANAB in Q3 2017 and held it in 27 quarters. The position peaked at $603K in Q1 2018. 135 funds tracked by Wall St. Rank hold ANAB as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining AnaptysBio position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,211 AnaptysBio shares in Q2 2024, an estimated $27.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in AnaptysBio in Q3 2017 and held it in 27 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s AnaptysBio position peaked at $603K in Q1 2018.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.